CollPlant Biotechnologies sets 2025 annual and extraordinary meeting

CollPlant Biotechnologies Ltd. reported that it will hold an annual and extraordinary general meeting of shareholders on December 31, 2025, at 10:00 a.m. Israel time.

Rhea-AI Filing Summary

CollPlant Biotechnologies Ltd. reported that it will hold an annual and extraordinary general meeting of shareholders on December 31, 2025, at 10:00 a.m. Israel time. The meeting will take place at the offices of Goldfarb Gross Seligman & Co. in the Azrieli Center in Tel-Aviv, Israel.

To support this meeting, CollPlant is providing a notice and proxy statement and a proxy card for holders of ordinary shares. The report is also incorporated by reference into several of the company’s existing Form S-8 and Form F-3 registration statements, meaning those registration statements will now include this information as part of their disclosure record.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is CollPlant Biotechnologies (CLGN) holding its 2025 shareholder meeting?

CollPlant Biotechnologies will hold its annual and extraordinary general meeting of shareholders on December 31, 2025, at 10:00 a.m. Israel time.

Where will the CollPlant (CLGN) 2025 general meeting of shareholders take place?

The general meeting will be held at the offices of Goldfarb Gross Seligman & Co. at One Azrieli Center, Round Building, 40th Floor, Tel-Aviv, Israel.

What documents did CollPlant (CLGN) provide in connection with the 2025 general meeting?

CollPlant provided a Notice and Proxy Statement for the annual and extraordinary general meeting of shareholders and a Proxy Card for holders of ordinary shares.

How is this CollPlant (CLGN) Form 6-K used in existing registration statements?

The Form 6-K is incorporated by reference into CollPlant’s Form S-8 and Form F-3 registration statements listed in the report, making its contents part of those filings.

Which CollPlant (CLGN) shareholders can use the proxy card mentioned in the filing?

The proxy card furnished with the report is intended for holders of ordinary shares of CollPlant Biotechnologies Ltd.

What type of meeting is CollPlant (CLGN) convening on December 31, 2025?

CollPlant is convening an annual and extraordinary general meeting of shareholders, combining routine annual matters with additional special items.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/26/2025 - 04:15 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-38370

CollPlant Biotechnologies Ltd.

(Exact name of registrant as specified in its charter)

4 Oppenheimer St, Weizmann Science Park

Rehovot 7670104, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒          Form 40-F ☐

This Form 6-K is hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File No. 333-229163, 333-248479, 333-263842, 333-271320 and 333-279791) and Form F-3 (File No. 333-238731 and 333-269087), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

On November 26, 2025, CollPlant Biotechnologies Ltd. (the “Company”) announced that on December 31, 2025, it will hold at the offices of Goldfarb Gross Seligman & Co. at One Azrieli Center, Round Building, 40th Floor, Tel-Aviv, Israel, an annual and extraordinary general meeting of shareholders (the “General Meeting”) at 10:00 a.m. Israel time. In connection with the meeting, the Company furnishes the following documents:

1. A copy of the Notice and Proxy Statement with respect to the General Meeting describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting, attached hereto as Exhibit 99.1; and

2. A form of Proxy Card whereby holders of ordinary shares of the Company may vote at the General Meeting without attending in person, attached hereto as Exhibit 99.2.

1

Exhibit Index

Exhibit No.		Description
99.1		Notice and Proxy Statement with respect to the Company’s Annual and Extraordinary General Meeting of Shareholders
99.2		Proxy Card for holders of ordinary shares with respect to the Company’s Annual and Extraordinary General Meeting of Shareholders

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	COLLPLANT BIOTECHNOLOGIES LTD.
Date: November 26, 2025	By:	/s/ Eran Rotem
		Name:	Eran Rotem
		Title:	Deputy CEO and Chief Financial Officer

3